Clinical heterogeneity: responders to cholinergic therapy

Clinical Alzheimer disease (AD) is a heterogeneous disorder, and it is possible to subgroup patients by a number of different criteria. One such subgrouping is those who have a positive response to cholinergic therapy and those who do not. This phenomenon has been clearly recognised in a number of t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer disease and associated disorders 1995, Vol.9 Suppl 2, p.37-42
Hauptverfasser:	Eagger, S A, Harvey, R J
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Cholinergic Agents - therapeutic use Clinical Trials as Topic Dose-Response Relationship, Drug Humans Probability Tacrine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!